Casdin Capital, LLC Standard Biotools Inc. Transaction History
Casdin Capital, LLC
- $713 Million
- Q2 2025
A detailed history of Casdin Capital, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Casdin Capital, LLC holds 76,075,636 shares of LAB stock, worth $99.7 Million. This represents 12.8% of its overall portfolio holdings.
Number of Shares
76,075,636
Previous 76,075,636
-0.0%
Holding current value
$99.7 Million
Previous $82.2 Million
11.11%
% of portfolio
12.8%
Previous 9.61%
Shares
5 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Viking Global Investors LP58.7MShares$76.8 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.2 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$13.2 Million0.56% of portfolio
-
Geode Capital Management, LLC Boston, MA7.44MShares$9.75 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $103M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...